• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铂类配合物通过抑制 SREBP 介导的脂质生物合成和激活多种抗癌机制:赋予新抗肿瘤策略的可能性。

Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies.

机构信息

Inner Mongolia University Research Center for Glycochemistry of Characteristic Medicinal Resources, Department of Chemistry and Chemical Engineering, Inner Mongolia University, Hohhot, 010021, People's Republic of China.

Institute of Integrative Biosciences, CECOS University of IT and Emerging Sciences, Peshawar, KPK, Pakistan; Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai, 200241, People's Republic of China.

出版信息

Eur J Med Chem. 2022 Jan 5;227:113920. doi: 10.1016/j.ejmech.2021.113920. Epub 2021 Oct 14.

DOI:10.1016/j.ejmech.2021.113920
PMID:34742012
Abstract

Cancer is one of the most aggressive diseases with poor prognosis and survival rates. Lipids biogenesis play key role in cancer progression, metastasis and tumor development. Suppression of SREBP-mediated lipid biogenesis pathway has been linked with cancer inhibition. Platinum complexes bearing good anticancer effect and multiple genes activation properties are considered important and increase the chances for development of new platinum-based drugs. In this study, we synthesized pyridine co-ligand functionalized cationic complexes and characterized them using multiple spectroscopic and spectrophotometric methods. Two of these complexes were studied in solid state by single crystal X-ray analysis. The stability of these complexes were measured in solution state using H NMR methods. These complexes were further investigated for their anticancer activity against human breast, lung and liver cancer cells. MTT assay showed potential cytotoxic activity in dose-dependent manner and decrease survival rates of cancer cells was observed upon treatment with these complexes. Biological assays results revealed higher cytotoxicity as compared to cisplatin and oxaliplatin. Further we studied C2, C6 and C8 in detailed mechanistic anticancer analyses. Clonogenic assay showed decrease survival of MCF-7, HepG2 and A549 cancer cells treated with C2, C6 and C8 as compared to control cells treated with DMSO. TUNEL assay showed more cell death, these complexes suppressed invasion and migration ability of cancer cells and decreased tumor spheroids formation, thus suggesting a potential role in inhibition of cancer metastasis and cancer stem cells formation. Mechanistically, these complexes inhibited sterol regulatory element-binding protein 1 (SREBP-1) expression in cancer cells in dose-dependent manner and thereby reduced lipid biogenesis to suppress cancer progression. Furthermore, expression level was decreased for the key genes LDLR, FASN and HMGCR, those required for sterol biosynthesis. Taken together, these complexes suppressed cancer cell growth, migration, invasion and spheroids formation by inhibiting SREBP-1 mediated lipid biogenesis pathway.

摘要

癌症是预后和生存率最差的最具侵袭性的疾病之一。脂类生物发生在癌症进展、转移和肿瘤发展中起着关键作用。抑制 SREBP 介导的脂类生物发生途径与癌症抑制有关。具有良好抗癌作用和多种基因激活特性的铂配合物被认为是重要的,并增加了开发新的基于铂的药物的机会。在这项研究中,我们合成了吡啶共配体功能化的阳离子配合物,并使用多种光谱和分光光度法对其进行了表征。其中两种配合物通过单晶 X 射线分析在固态下进行了研究。使用 H NMR 方法在溶液状态下测量了这些配合物的稳定性。进一步研究了这些配合物对人乳腺癌、肺癌和肝癌细胞的抗癌活性。MTT 测定法显示出剂量依赖性的潜在细胞毒性活性,并观察到用这些配合物处理后癌细胞的存活率降低。生物测定结果显示,与顺铂和奥沙利铂相比,这些配合物具有更高的细胞毒性。进一步我们详细研究了 C2、C6 和 C8 的抗肿瘤机制。集落形成实验显示,与用 DMSO 处理的对照细胞相比,C2、C6 和 C8 处理的 MCF-7、HepG2 和 A549 癌细胞的存活率降低。TUNEL 分析显示更多的细胞死亡,这些配合物抑制了癌细胞的侵袭和迁移能力,并减少了肿瘤球体的形成,因此提示其在抑制癌症转移和癌症干细胞形成方面具有潜在作用。从机制上讲,这些配合物以剂量依赖性方式抑制癌细胞中固醇调节元件结合蛋白 1 (SREBP-1)的表达,从而减少脂质生物发生以抑制癌症进展。此外,关键基因 LDLR、FASN 和 HMGCR 的表达水平降低,这些基因是固醇生物合成所必需的。综上所述,这些配合物通过抑制 SREBP-1 介导的脂类生物发生途径抑制癌细胞生长、迁移、侵袭和球体形成。

相似文献

1
Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies.铂类配合物通过抑制 SREBP 介导的脂质生物合成和激活多种抗癌机制:赋予新抗肿瘤策略的可能性。
Eur J Med Chem. 2022 Jan 5;227:113920. doi: 10.1016/j.ejmech.2021.113920. Epub 2021 Oct 14.
2
Co-targeting CDK 4/6 and C-MYC/STAT3/CCND1 axis and inhibition of tumorigenesis and epithelial-mesenchymal-transition in triple negative breast cancer by Pt(II) complexes bearing NH as trans-co-ligand.含 NH 作为反式配位体的 Pt(II) 配合物对三阴性乳腺癌中 CDK4/6 和 C-MYC/STAT3/CCND1 轴的共靶向作用及对肿瘤发生和上皮-间充质转化的抑制作用。
J Inorg Biochem. 2024 Oct;259:112661. doi: 10.1016/j.jinorgbio.2024.112661. Epub 2024 Jul 6.
3
Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.吗啉或甲基哌嗪与水杨醛亚胺基的杂配体平面正方形铂(II)配合物:体外抗癌研究及对大肠杆菌的生长抑制作用
Eur J Med Chem. 2017 May 5;131:263-274. doi: 10.1016/j.ejmech.2017.03.014. Epub 2017 Mar 18.
4
Salicylaldehyde-derived piperazine-functionalized hydrazone ligand-based Pt(II) complexes: inhibition of EZH2-dependent tumorigenesis in pancreatic ductal adenocarcinoma, synergism with PARP inhibitors and enhanced apoptosis.水杨醛衍生的哌嗪官能化腙配体基Pt(II)配合物:抑制胰腺导管腺癌中EZH2依赖性肿瘤发生、与PARP抑制剂协同作用并增强细胞凋亡
Dalton Trans. 2024 Aug 20;53(33):13871-13889. doi: 10.1039/d4dt01243g.
5
Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.ONN 供体腙和 4-吡啶基同系物和异种 Pt(II)配合物:合成、结构和详细的抗癌机制研究。
Eur J Med Chem. 2018 Jan 1;143:1039-1052. doi: 10.1016/j.ejmech.2017.11.044. Epub 2017 Nov 26.
6
Monofunctional dimetallic Ru(η6-arene) complexes inhibit NOTCH1 signaling pathway and synergistically enhance anticancer effect in combination with cisplatin or vitamin C.单核二价钌(η6-芳基)配合物抑制 NOTCH1 信号通路,并与顺铂或维生素 C 联合使用具有协同的抗癌作用。
Eur J Med Chem. 2023 Oct 5;258:115536. doi: 10.1016/j.ejmech.2023.115536. Epub 2023 May 30.
7
Palladium and platinum complexes based on pyridine bases induced anticancer effectiveness via apoptosis protein signaling in cancer cells.基于吡啶碱基的钯和铂配合物通过癌细胞中的凋亡蛋白信号诱导抗癌效果。
Biometals. 2024 Aug;37(4):905-921. doi: 10.1007/s10534-023-00580-z. Epub 2024 Feb 15.
8
Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling.双水杨醛亚胺负载的二金属钌(II)芳基金属配合物通过依赖 p53 的信号通路诱导癌细胞死亡和抑制侵袭。
Eur J Med Chem. 2018 Sep 5;157:1480-1490. doi: 10.1016/j.ejmech.2018.08.054. Epub 2018 Aug 21.
9
Biological evaluation of dimethylpyridine-platinum complexes with potent antiproliferative activity.具有强效抗增殖活性的二甲基吡啶铂配合物的生物学评价。
J Enzyme Inhib Med Chem. 2016;31(sup3):150-165. doi: 10.1080/14756366.2016.1212191. Epub 2016 Aug 4.
10
Novel oximato-bridged platinum(II) di- and trimer(s): synthetic, structural, and in vitro anticancer activity studies.新型氧桥联铂(II)二聚体和三聚体的合成、结构及体外抗癌活性研究。
Inorg Chem. 2012 Jul 2;51(13):7153-63. doi: 10.1021/ic300148e. Epub 2012 Jun 12.

引用本文的文献

1
Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9.升高的固醇调节元件结合蛋白1通过靶向SOX9加速胰腺癌的起始和生长。
Biol Direct. 2025 Jan 14;20(1):6. doi: 10.1186/s13062-025-00595-1.
2
Regulation and targeting of SREBP-1 in hepatocellular carcinoma.SREBP-1 在肝细胞癌中的调控和靶向治疗。
Cancer Metastasis Rev. 2024 Jun;43(2):673-708. doi: 10.1007/s10555-023-10156-5. Epub 2023 Dec 1.
3
Expression of housekeeping genes varies depending on mevalonate pathway inhibition in cancer cells.
管家基因的表达因癌细胞中甲羟戊酸途径的抑制而有所不同。
Heliyon. 2023 Jul 8;9(7):e18017. doi: 10.1016/j.heliyon.2023.e18017. eCollection 2023 Jul.
4
Recent Trends in the Development of Novel Metal-Based Antineoplastic Drugs.新型金属抗肿瘤药物的研究进展。
Molecules. 2023 Feb 18;28(4):1959. doi: 10.3390/molecules28041959.
5
Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.脂肪酸合酶介导的从头脂质合成增强诱导结直肠癌化疗耐药。
Cancers (Basel). 2023 Jan 17;15(3):562. doi: 10.3390/cancers15030562.
6
Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.靶向SREBP-1介导的脂肪生成作为癌症的潜在治疗策略
Front Oncol. 2022 Jul 14;12:952371. doi: 10.3389/fonc.2022.952371. eCollection 2022.